BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1248 related articles for article (PubMed ID: 27166317)

  • 1. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
    Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
    Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
    Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
    Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Willrich MAV; Murray DL; Kyle RA
    Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biclonal gammopathy of kappa light chain type in a case of multiple myeloma.
    Rabhi H; Ghaffor M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():141-50. PubMed ID: 2518743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
    Pretorius CJ
    Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure Red Cell Aplasia Associated with Monoclonal Gammopathy of Undetermined Significance and Literature Review.
    Gu H; Lee WI; Jeon Y; Kang SY; Kim MH; Park TS
    Clin Lab; 2017 Feb; 63(2):373-378. PubMed ID: 28182355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
    Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes in biclonal gammopathies.
    Mullikin TC; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lin Y; Dingli D; Go RS; Hayman SR; Zeldenrust SR; Russell SJ; Lust JA; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
    Am J Hematol; 2016 May; 91(5):473-5. PubMed ID: 26840395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M-Proteins) in dogs with multiple myeloma and related disorders: Part 1 - Current performance.
    Moore AR; Harris RA; Jeffries C; Ashton L; Avery PR
    Vet Clin Pathol; 2021 Jun; 50(2):240-248. PubMed ID: 33847384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Berenson JR; Lichtenstein A; Hart S; Palomares D; Miller RA
    Blood; 1990 Jun; 75(11):2107-11. PubMed ID: 1693294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level].
    Kanoh T
    Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
    Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
    Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.